Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer - Overman, M J; Lonardi, S; Wong, K YM (J Clin Oncol, 2018)